David Shaw’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
Other funds holding PRLD
BBA
KCM
David Shaw's PRLD Position: Q3 2026 in Review
David Shaw opened a new position in Prelude Therapeutics (PRLD) in Q3 2026: 24,409 shares worth $95.4K. The stake represents ﹤0.01% of the portfolio and ranks #4714 among its holdings. This is a return to the name: David Shaw previously reported a position in PRLD as recently as Q3 2023.
David Shaw first reported a position in PRLD in Q1 2021 and has held it in 9 quarters since. The position peaked at $605K in Q2 2022. 92 funds tracked by Wall St. Rank hold PRLD as of Q3 2026.
- David Shaw held 24,409 shares of Prelude Therapeutics worth $95.4K as of Q3 2026.
- Prelude Therapeutics was a new David Shaw position in Q3 2026.
- Prelude Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4714 holding.
- David Shaw first reported a position in Prelude Therapeutics in Q1 2021 and has held it in 9 quarters since.
- David Shaw's Prelude Therapeutics position peaked at $605K in Q2 2022.
- 92 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.